Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 62 | 62 | 67 | 65 | 58 |
| Accounts receivable | 75 | -37 | 10 | 15 | 103 |
| Other Working Capital | 782 | -31 | 1,538 | -181 | 1,381 |
| Other Operating Activity | -5,694 | -6,916 | -8,080 | -3,314 | -6,897 |
| Operating Cash Flow | $-4,776 | $-6,923 | $-6,465 | $-3,415 | $-5,354 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -3 | -11 | -6 | -4 |
| Investing Cash Flow | $-4 | $-3 | $-11 | $-6 | $-4 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9 | -14 | -14 | -14 | -14 |
| Other Financing Activity | 87 | 90 | 0 | 0 | 0 |
| Financing Cash Flow | $78 | $76 | $-14 | $-14 | $-14 |
| Exchange Rate Effect | 150 | 491 | 881 | -968 | 847 |
| Beginning Cash Position | 28,573 | 34,932 | 40,540 | 44,942 | 49,468 |
| End Cash Position | 24,021 | 28,573 | 34,932 | 40,540 | 44,942 |
| Net Cash Flow | $-4,701 | $-6,850 | $-6,489 | $-3,434 | $-5,372 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,776 | -6,923 | -6,465 | -3,415 | -5,354 |
| Capital Expenditure | -4 | -3 | -11 | -6 | -4 |
| Free Cash Flow | -4,780 | -6,926 | -6,475 | -3,420 | -5,358 |